Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2023 | The impact of CEBPA mutations & insights into the gene regulatory network of CEBPA-double mutant AML

Constanze Bonifer • 16 Mar 2023
ISAL 2023
Acute Myeloid Leukemia Leukemia

Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, shares some insights into the role of CEBPA in the pathology of acute myeloid leukemia (AML), and further discusses research investigating the gene regulatory network of CEBPA-double mutant AML. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Constanze Bonifer

3:48
The impact of various chromosomal abnormalities observed in AML & insights into RUNX1-ETO
Constanze Bonifer • 16 Mar 2023
4:09
Using transcriptional network analysis to better understand AML development and evolution
Constanze Bonifer • 16 Mar 2023
3:18
The molecular impact of RUNX1 mutations in AML
Constanze Bonifer • 16 Mar 2023
1:31
Identifying the factors in gene regulatory networking in AML
Constanze Bonifer • 8 Nov 2019

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals